viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Sulfadiazine
keemiline struktuur
Viited : Sulfadiazine
tüüp
avaldamine
2795
ajaleht
Pathmanathan U, Halgrain D, Chiadmi F, Schlmatter J, Vermerie N.
Stability of sulfadiazine oral liquids prepared from tablets and powder.
J Pharm Pharm Sci 2004 ; 7, 1: 84-87.
3819
ajaleht
Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B.
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
J Pharm Biomed Anal 2015 ; 118: 105-112.
4030
ajaleht
Graves R, Phan K, Bostanian L, Mandal T, Pramar Y.
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.
Int J Pharm Compound 2017 ; 21, 5 : 430-435
4789
ajaleht
Micheline Silva Dias, Amanda Maccangnan Zamberlan, Rebeca Lino Lourenço, Emanuele Saul Saraiva, Julya Sarmento Neis et al.
Stability of sulfadiazine sugar-free oral suspensions for the treatment of congenital toxoplasmosis.
Braz J Pharm Sci 2023 ; 59: e23359.
Mentions Légales